CS1 Selleck PLX3397 promotes multiple myeloma cell adhesion, clonogenic growth and tumorigenicity via cmaf-mediated interactions with bone marrow stromal cells [42]. Family-based association studies

in UK and Canadian SLE families identified variants in the promoter and coding region of CS1 contributing to SLE disease susceptibility [43]. Based on the recent finding of a genetic association of SLAM family receptors with SLE, we hypothesized that the alterations in expression of 2B4 and CS1 may mediate the immune dysregulation observed in patients with SLE. In this study, we compared expression levels of 2B4 and CS1 on T, B, NK cells and monocytes in SLE patients versus those of healthy controls. The 2B4-expressing NK cells and 2B4-expressing monocytes were reduced in patients with SLE compared to healthy controls. The proportion of CS1-expressing B cells in patients with SLE was significantly higher than that from healthy controls. Our study also demonstrated differential expression of CS1 and

2B4 splice variants in total peripheral blood mononuclear cells (PBMC) in patients with SLE compared to healthy controls. Blood samples were obtained from 45 patients diagnosed with https://www.selleckchem.com/products/PD-0325901.html SLE (two males, 43 females) at John Peter Smith (JPS) Hospital, Fort Worth, TX and from 30 healthy volunteers at University of North Texas Health Science Center (UNTHSC), Fort Worth, TX with prior approval from Internal Review Board of JPS Health Network and UNTHSC. Written informed consents were obtained from all of the study subjects. Patients with SLE were classified according to the 1997 revised criteria from the American College of Rheumatology [44,45]. Clinical and demographic characteristics of SLE patients, including SLE Disease Activity Olopatadine Index (SLEDAI), treatments, major disease manifestations and serological parameters, are

shown in Table 1. Eight patients had active SLE, defined by a SLEDAI score of ≥8 [46]. All 45 patients were positive for anti-nuclear antibody (ANA). PBMCs were isolated from ethylenediamine tetraacetic acid (EDTA)-treated whole-blood samples by Histopaque-1077 (Sigma Chemicals, St Louis, MO, USA) density gradient centrifugation using LeucoSep tubes (Greiner, Monroe, NC, USA). The remaining red blood cells were lysed with ACK lysis buffer. Resulting PBMCs were used for immunostaining or reverse transcription–polymerase chain reaction (RT–PCR). Before starting immunostaining, PBMCs were incubated with human IgG Fc fragments (Rockland, PA, USA) for prevention of possible Fc receptor-mediated fluorescence. The tricolour staining [fluorescein isothiocyanate–phycoerythrin–allophycocyanin (FITC-PE-APC)] method was applied for immunostaining.